knowledge -WSS

knowledge

author：focus 2025-08-25 07:29:51 - browse：9616

De-Shaine Murray is working at the cutting edge of neurotechnology. As a postdoctoral fellow at Yale, he is developing a device to monitor the brain following traumatic brain injury or stroke.

He is also trying to fight the long legacy of racism in neuroscience. During 2020, when it was difficult to conduct research, he said, “I got the chance and the ability to read more widely and to just look into the legacy of neuroscience.” He found a direct line from racist pseudoscience like phrenology to disparities in neuroscience today, like how the texture of Black people’s hair can sometimes exclude them from clinical trials because electrodes are not designed for them. In 2021, he co-founded Black in Neuro, an organization dedicated to improving Black representation in neuroscience.

On this episode of the “First Opinion Podcast,” I spoke to him about how the past and present racism in neuroscience could be reflected in the future, especially as neurotechnology like brain implants become more common.

“I’m not saying that whatever electrode that you made or created is racist. But when you have someone who … creates a technology but doesn’t think about the wide range of users that are potentially going to use it, then that’s where the problem comes in,” he told me.

We also discussed the way inequities in neuroscience research are visible in stroke wards, how brain implants might jump from helping disabled people to being used for human enhancement, and more.

Our conversation was inspired by his recent First Opinion essay, “Neuroscience has to grapple with a long legacy of racism if it wants to move into the future.” The book I mention at the end is “Lock In” by John Scalzi, a great sci-fi mystery exploring themes of race, socioeconomic status, neurotechnology, and more.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

Previous article： Cancer drug shortages should be causing more outrage
Next article： Methadone treatment changes are coming. Do they go far enough?

WSS

Health AI adoption puts security, privacy startups on investors' radar

Creating egg and sperm cells from stem cells raises ethical issues

Intermittent fasting comes with a heart risk? Not so fast

States increasingly look to regulate hospital facility fees

States increasingly look to regulate hospital facility fees

Trump got a 'target letter.' What is one and what does it mean?

explore

knowledge

LETTER TO THE EDITOR

Have an opinion on this essay? Submit a letter to the editor here.

entertainment

Sports medicine is finally prioritizing gender equality

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Continuity nursing helped my family in our darkest PICU moments

Gene editing the human germline: What are the risks?

In Memoriam: Notable people who died in 2023

Physicians and social media: If you see something, say something?

Hepatitis C has a cure — but many Americans still lack access to it

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Medicare details structure of new drug price negotiation program

UnitedHealth increases loan offers after Change Healthcare outage

focus

Researchers separate signal from noise in heart wearable data

5 to watch: Tech startups trying to solve health care's staffing crisis

The kidney, in all its complexity, is captured in a new atlas

New warning issued for rebooking air travel after delays, cancellations

AstraZeneca to buy developer of next

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

explore

explore

knowledge

Wikipedia